[1]
“EVALUATION OF THE USE OF THE DRUG IN PATIENTS ACUTE RESPIRATORY TRACT INFECTION (ARI) NON PNEUMONIA AT PUSKESMAS SIGUMPAR”, JFM, vol. 6, no. 1, pp. 9–16, Oct. 2023, doi: 10.35451/jfm.v6i1.1630.